**Abbreviations**



**References**

(16)30321-4/fulltext

1998;**15**(6):16-20

[1] Frid AH et al. New insulin delivery recommendations. Mayo Clinic Proceedings; **91**(9): 1231-1255. Open Access at: http://www.mayoclinicproceedings.org/article/S0025-6196

Optimal Insulin Delivery

69

http://dx.doi.org/10.5772/intechopen.76232

[2] Strauss K. Insulin injection techniques: Report from the 1st international insulin injection technique workshop, Strasbourg, France—June 1997. Practical Diabetes International.

[3] Strauss K, De Gols H, Letondeur C, Matyjaszczyk M, Frid A. The second injection technique event (SITE), May 2000, Barcelona. Practical Diabetes International. 2002;**19**(1):17-21

[4] Frid A, Hirsch L, Gaspar R, Hicks D, et al. New injection recommendations for patients

[5] Frid AH et al. Worldwide injection technique questionnaire study: Population parameters and injection practices. Mayo Clinic Proceedings. 2016;**91**:1212-1223. Open Access

[6] Frid AH et al. Worldwide injection technique questionnaire study: Injecting complications and role of the professional. Mayo Clinic Proceedings. 2016;**91**:1224-1230. Open Access at: http://www.mayoclinicproceedings.org/article/S0025-6196(16)30326-3/fulltext

[7] Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: Implications for needle length recommendations. Current Medical Research and Opinion. 2010;**26**(6):1519-1530

[8] Hirsch L, Klaff L, Bailey T, Gibney M, Albanese J, Qu S, Kassler-Taub K. Comparative glycemic control, safety and patient ratings for a new 4 mm\32G insulin pen needle in

[9] Catambing I, Villa M. Ultrasonographic measurement of skin and subcutaneous thickness at insulin injection sites among adult Filipinos with diabetes. Journal of the ASEAN

[10] Sim KH, Hwang MS, Kim SY, Lee HM, Chang JY, Lee MK. The appropriateness of the length of insulin needles based on determination of skin and subcutaneous fat thickness in the abdomen and upper arm in patients with type 2 diabetes. Diabetes and

[11] Wang W, et al. Skin and subcutaneous layer thickness at insulin injection sites in Chinese diabetic patients. Diabetes Technology & Therapeutics. 2014 Dec;**16**(12):867-873. DOI:

[12] Jain SM, Pandey K, Lahoti A, Rao PK. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naïve, type-2 diabetic adult population.

Indian Journal of Endocrinology and Metabolism. 2013;**17**(5):864-870

adults with diabetes. Current Medical Research and Opinion. 2010;**26**:1531-1541

at: http://www.mayoclinicproceedings.org/article/S0025-6196(16)30322-6/fulltext

with diabetes. Diabetes & Metabolism. 2010;**36**(2):S3-S18

Federation of Endocrine Societies. 2014;**29**(1):24-32

Metabolism Journal. 2014;**38**(2):120-133

10.1089/dia.2014.0111. Epub 2014 Oct 20
